Cite

HARVARD Citation

    Asphaug, L. et al. (2019). The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway. MDM policy & practice. 4 (1), p. . [Online]. 
  
Back to record